Over about 84 weeks, people taking CagriSema lost around 23% of their body weight, while those on Zepbound lost about 25.5% at its highest dose
Recognition of Damage-Associated Molecular Patterns Related to Nucleic Acids during Inflammation and Vaccination
Across all six studies, the safety findings were consistent: no serious adverse events, no immunogenic responses, no changes in IGF-1, no glucose or insulin disruption
Our providers can review your goals, discuss your options, and help determine whether peptide therapy is appropriate for your needs
Let your nurse know about any medications you're taking or symptoms you're having that day
So happy I switched to Brello